Immune Modulation During Palynziq® Treatment in Adults (IMPALA) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Immune Modulation During Palynziq® Treatment in Adults (IMPALA)	Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, brain disorder, central nervous system disorder, hereditary disease, inborn disorder of amino acid metabolism, inborn errors of metabolism, metabolic disease, nervous system disorder, phenylketonuria	Recruiting	Phase 4	2026-06-17		NCT07477691

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
BioMarin Pharmaceutical	32

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Ann & Robert H. Lurie Children's Hospital of Chicago	Chicago	United States	144
Children's Hospital Colorado	Aurora	United States	312
Children's Hospital of Wisconsin	Milwaukee	United States	87
Indiana University School of Medicine	Indianapolis	United States	71
Oregon Health & Science University (OHSU) - PARENT	Portland	United States	1
UCLA Dept. of Human Genetics	Los Angeles	United States	1
University of Minnesota Medical School	Minneapolis	United States	12
University of Pittsburgh Medical Center (UPMC) - Children's Hospital of Pittsburgh	Philadelphia	United States	1
University of Rochester Medical Center (URMC)	Rochester	United States	3
University Of South Florida Medical Center	Tampa	United States	1
University of Utah Hospital	Salt Lake City	United States	2
UT Southwestern Medical Center	Dallas	United States	210